Detalles de la búsqueda
1.
Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific membrane antigen (PSMA), and prostate-specific antigen (PSA) gene expression in CTCs and plasma exosome-derived cfRNA in patients with metastatic castration-resistant prostate cancer (mCRPC) by integrating the VTX-1 CTC isolation system with the QIAGEN AdnaTest.
BMC Cancer
; 24(1): 482, 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38627648
2.
Detection of EGFR Mutations in cfDNA and CTCs, and Comparison to Tumor Tissue in Non-Small-Cell-Lung-Cancer (NSCLC) Patients.
Front Oncol
; 10: 572895, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33117705
3.
Label-free isolation of prostate circulating tumor cells using Vortex microfluidic technology.
NPJ Precis Oncol
; 1(1): 15, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29872702
4.
Workflow optimization of whole genome amplification and targeted panel sequencing for CTC mutation detection.
NPJ Genom Med
; 2: 34, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29263843
5.
Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.
Oncotarget
; 7(51): 85349-85364, 2016 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27863403
Resultados
1 -
5
de 5
1
Próxima >
>>